Volume 23, Issue 4 pp. 296-302
Case Report
Open Access

Suppression of Ventricular Tachycardia Associated with Cardiac Sarcoidosis by Steroid Therapy

Kotaro Miyaji MD

Kotaro Miyaji MD

Department of Cardiology, Kameda Medical Center

Search for more papers by this author
Makoto Suzuki MD

Makoto Suzuki MD

Department of Cardiology, Kameda Medical Center

Search for more papers by this author
Akira Mizukami MD

Akira Mizukami MD

Department of Cardiology, Kameda Medical Center

Search for more papers by this author
Ryota Iwatsuka MD

Ryota Iwatsuka MD

Department of Cardiology, Kameda Medical Center

Search for more papers by this author
Reon Kumasaka MD

Reon Kumasaka MD

Department of Cardiology, Kameda Medical Center

Search for more papers by this author
Naoaki Ichihara MD

Naoaki Ichihara MD

Department of Cardiology, Kameda Medical Center

Search for more papers by this author
Wataru Nagahori MD

Wataru Nagahori MD

Department of Cardiology, Kameda Medical Center

Search for more papers by this author
Masakazu Oono MD

Masakazu Oono MD

Department of Cardiology, Kameda Medical Center

Search for more papers by this author
Tetsuo Arakawa MD

Tetsuo Arakawa MD

Department of Cardiology, Kameda Medical Center

Search for more papers by this author
Nobuyuki Masaki MD

Nobuyuki Masaki MD

Department of Cardiology, Kameda Medical Center

Search for more papers by this author
Akihiko Matsumura MD

Akihiko Matsumura MD

Department of Cardiology, Kameda Medical Center

Search for more papers by this author
Yuji Hashimoto MD

Yuji Hashimoto MD

Department of Cardiology, Kameda Medical Center

Search for more papers by this author
First published: 23 August 2012
Citations: 1
Address for correspondence: Kotaro Miyaji MD, Department of Cardiology, Kameda Medical Center, 929 Higashicho, Kamogawa, Chiba 296-8602, Japan. Fax: 04-7099-1191 Tel: 04-7092-2211

Abstract

In patients with cardiac sarcoidosis, ventricular tachycardia (VT) is observed in some cases. However, effective therapies for the VT are still unknown.

Case: A 50-year old female with cardiac sarcoidosis underwent DDD pacemaker implantation for a high degree atrioventricular block with symptoms of faintness and shortness of breath. One month after the surgery, she was admitted for frequent episodes of non-sustained VT. In the electrophysiologic study (EPS), sustained monomorphic VT and ventricular fibrillation were induced; therefore pacemaker was replaced with implantable cardioverter-defibrillator (ICD). Amiodarone was started orally but it couldn't suppress frequent VT episodes, and frequent ICD shocks were delivered. When the oral steroid therapy was initiated for the cardiac sarcoidosis, it not only suppressed the frequent VT but also improved the atrioventricular nodal dysfunction.

In conclusion, steroid therapy might be an option to consider in cardiac sarcoidosis with refractory VT.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.